In this UCSF Department of Medicine Covid Grand Rounds, we’ll begin with a discussion of the new vaccine candidates. Just in the past few weeks, we’ve seen new data regarding several vaccines, including J&J, AstraZeneca, and Novavax. Dr. Monica Gandhi will review these new data, and discuss the implications for vaccine supply – and why it’s appropriate to be optimistic about vaccines, even in the face of a sluggish roll-out and the threat of variants. She’ll add a few thoughts about whether vaccinated people can change behavior. Dr. Marguerita Lightfoot then shares insights regarding communicating about vaccines – particularly to communities of color. Finally, Drs. Robert Rodriguez and Eric Goosby describe their experience as members of the Biden Covid-19 Task Force, which guided the early days of the new administration’s response to the pandemic. The session is moderated by UCSF Department of Medicine chair Bob Wachter.
The New Vaccines
00:06:14-00:34:50 – The New Vaccines: Monica Gandhi, MD, MPH (Professor of Medicine; Associate Chief of Division of HIV, Infectious Diseases, and Global Medicine at ZSFG; Director of the UCSF-Gladstone Center for AIDS Research; and Medical Director of the HIV Clinic, Ward 86, ZSFG)
00:39:34-00:51:52 – Q&A with Marguerita Lightfoot, PhD (Professor of Medicine; Chief of Division of Prevention Science; Director of the Center for AIDS Prevention Studies and Prevention Research Center)
President Biden’s Covid-19 Task Force
00:52:02-01:15:27 – President Biden’s Covid-19 Task Force: Eric Goosby, MD (Professor of Medicine; UN Special Envoy on Tuberculosis; Member of President Biden’s Covid-19 Task Force) and Robert Rodriguez, MD (Professor of Emergency Medicine; Member of President Biden’s Covid-19 Task Force)